ClinVar Miner

Submissions for variant NM_016356.5(DCDC2):c.278C>A (p.Ala93Asp)

gnomAD frequency: 0.00001  dbSNP: rs776415168
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Baylor Genetics RCV001335812 SCV001529050 uncertain significance Autosomal recessive nonsyndromic hearing loss 66 2018-04-27 criteria provided, single submitter clinical testing This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].
Fulgent Genetics, Fulgent Genetics RCV002499662 SCV002814207 uncertain significance Autosomal recessive nonsyndromic hearing loss 66; Nephronophthisis 19; Isolated neonatal sclerosing cholangitis 2021-12-07 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003918863 SCV004735202 uncertain significance DCDC2-related disorder 2023-12-21 no assertion criteria provided clinical testing The DCDC2 c.278C>A variant is predicted to result in the amino acid substitution p.Ala93Asp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0040% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-24357701-G-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.